Orgullosa de formar parte de la red de investigadoras de la Fundación Científica AECC. Para mí, investigar en cáncer significa transformar el conocimiento en esperanza.
#InvestigadoraContraelCancerAECC
#DiaInternacionaldelaMujerylaNiñaenlaCiencia #11F
@contracancerinv.bsky.social
@vhio.bsky.social
Do you want your research to make a real difference in health? 💡🩺
Our Call is now open for projects in Spain and Portugal.
Discover it and apply! 👇
https://tinyurl.com/5yjman5k
Drug-tolerant persisters #DTP, a rare subpopulation of cancer cells, can survive therapy via reversible non-genetic mechanisms. @seansi.bsky.social lab provide their #perspective on the gaps and research paths still needed to bridge basic DTP research with the clinic. www.nature.com/articles/s41...
Muchísimas Felicidades María!!!! A ti y a tu equipo 👏👏👏👏👏👏
Our latest paper in @natcomms.nature.com is here!
➡️Cx43 sensitizes BRAF-mutant tumors to BRAF/MEK inhibitors by impairing DNA repair
🔗Open access PDF: rdcu.be/euQkW
What a fantastic conference we’ve had this week in Lyon, shining the spotlight on the rapidly evolving area of research that is cancer persister cells. Thank you to all participants, speakers and our wonderful Scientific Programme Committee 🤩
Many thanks to the organizers of "Persister Cells: From Bacteria to Cancer" @helloeacr.bsky.social for the opportunity to present our results on CRC persistence. Excited about our group’s strong representation which allowed us to establish new collaborations. Looking forward to next year’s event!
Ready to start the EACR Conference_Persister Cells: from Bacteria to Cancer in Lyon!!!
@helloeacr.bsky.social @vhio.bsky.social
Protein organ clocks, as assessed in over 6,000 people (~4,000 plasma proteins, 8 organs) with 20-year follow-up are predictive for over 30 age-related diseases
www.thelancet.com/journals/lan...
Thanks to those who politely pointed out we initially made a list of Metastasis Researchers... we've now made a starter pack! ☺️
go.bsky.app/KasKkhK
Drop us a message or reply here to be added.
More to follow over the coming days.
🦋
🔵 La 34 edició de La Marató 3cat es dedicarà al càncer
www.3cat.cat/tv3/marato/e...
Interview and article related to the international day of the fight against cancer when I visited Spain last November. Thanks for a wonderful interview - in spanish.
www.cartv.es/aragonradio/...
On this #WorldCancerDay, I want to revisit our published work on DPPA3 as a key regulator of therapy-resistant slow-cycling cancer cells that drive colorectal cancer persistence and relapse.
📝 Read our fully study here:
www.cell.com/cell-reports...
Opening the genetic gates in colon cancer!
This month’s cover features work by Linda Resar, Cindy Sears & team @harvardmed.bsky.social on an epigenetic gatekeeper of Wnt signaling in colon cancer: https://www.jci.org/articles/view/184442
Gracias Laura!!!
Muchas gracias Maria!!! 🤗🤗🤗
We are still looking for a #PhDstudent to join the @ERC_Research project #DORMATRIX, modeling #breastcancer #dormancy with novel #biomaterials. Bioengineers, (bio)chemists or similar.
@biogipuzkoa @Ikerbasque. More info & apply until 15/02 👉 bit.ly/3Wkd2eQ
Enormemente agradecida de ser una de las afortunadas en liderar uno de los proyectos de I+D+I en salud del ISCIII @saludisciii.bsky.social y contribuir en el avance de la investigación en el campo de la persistencia del cáncer.
Hello BlueSky community!!!
I'm excited to be here and connect with all of you! Looking forward to sharing ideas, discussing science, and collaborating.
Let's advance cancer research together!
